The company makes investments that can change lives by discovering and transforming deep technology Big Ideas into valuable public companies through a unique approach to public venture capital. This approach focuses on community-driven financings of pre-revenue, early-stage deep technology companies through early initial public offerings (IPOs), primarily listed on NASDAQ, as well as post-IPO offerings for already public companies that fit MDB's overall investment criteria. Its subsidiaries operate and provide services that includes MDB Capital, a self-clearing broker-dealer with the MDB Direct trading platform, and PatentVest, the first integrated, intellectual property (IP) intelligence, strategy consulting and IP law firm. MDB Capital is a registered broker-dealer, a member of FINRA and a member of SIPC.

A leading acquirer of private B2B SaaS companies in Latin America.

Headquartered in São Paulo, Brazil, the company focuses on acquiring profitable, high-growth SaaS businesses with strong recurring revenue and cash flow generation.

By fostering an entrepreneurial environment, Nuvini enables its portfolio companies to scale and maintain leadership within their respective industries.

The company’s long-term vision is to buy, retain, and create value through strategic partnerships and operational expertise

Renovaro aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube that is leveraging AI for multi-omic diagnostics and drug development, and BioSymetrics which specializes in contingent AI for precision neurology.